Progress of Radix Astragali and Radix Angelicae Sinensis in the treatment of idiopathic pulmonary fibrosis

TMR Integrative Medicine

article

Hui-Zhe Zhang¹  Cong Wang²  Yu-Feng Zhang² 

[1] Department of Respiratory Medicine, Yancheng Hospital Affiliated to Nanjing University of Chinese Medicine;Department of Pulmonary and Critical Care Medicine, Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine

关键词: idiopathic pulmonary fibrosis;    Radix Astragali;    Radix Angelicae Sinensis;    Danggui Buxue decoction;   

DOI  :  10.53388/TMRIM202206024

学科分类：医学（综合）

来源: TMR publishing group

【 摘 要 】

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lungdisease. Current treatment options for IPF are limited. Radix Astragali (RA) and Radix Angelicae Sinensis (RAS), according to 5:1 ratio composed of Danggui Buxue decoction(DGBXD), which have played an essential role in the treatment of IPF. This article reviewedthe experimental research, clinical research, and progress of RA and RAS (DGBXD) treatingIPF to provide a deeper scientific basis for the future experimental research and clinical research.

【 授权许可】

CC BY